Tettoni, E.; Gabbiadini, R.; Dal Buono, A.; Privitera, G.; Vadalà , V.; Migliorisi, G.; Bertoli, P.; Quadarella, A.; Bezzio, C.; Armuzzi, A.
TL1A as a Target in Inflammatory Bowel Disease: Exploring Mechanisms and Therapeutic Potential. Int. J. Mol. Sci. 2025, 26, 5017.
https://doi.org/10.3390/ijms26115017
AMA Style
Tettoni E, Gabbiadini R, Dal Buono A, Privitera G, Vadalà V, Migliorisi G, Bertoli P, Quadarella A, Bezzio C, Armuzzi A.
TL1A as a Target in Inflammatory Bowel Disease: Exploring Mechanisms and Therapeutic Potential. International Journal of Molecular Sciences. 2025; 26(11):5017.
https://doi.org/10.3390/ijms26115017
Chicago/Turabian Style
Tettoni, Enrico, Roberto Gabbiadini, Arianna Dal Buono, Giuseppe Privitera, Vincenzo Vadalà , Giulia Migliorisi, Peter Bertoli, Alessandro Quadarella, Cristina Bezzio, and Alessandro Armuzzi.
2025. "TL1A as a Target in Inflammatory Bowel Disease: Exploring Mechanisms and Therapeutic Potential" International Journal of Molecular Sciences 26, no. 11: 5017.
https://doi.org/10.3390/ijms26115017
APA Style
Tettoni, E., Gabbiadini, R., Dal Buono, A., Privitera, G., Vadalà , V., Migliorisi, G., Bertoli, P., Quadarella, A., Bezzio, C., & Armuzzi, A.
(2025). TL1A as a Target in Inflammatory Bowel Disease: Exploring Mechanisms and Therapeutic Potential. International Journal of Molecular Sciences, 26(11), 5017.
https://doi.org/10.3390/ijms26115017
